Cipta Sarana Medika Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 20.97M 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 312.28B, 3.89M 24h volume). The key difference: Kian Santang Muliatama Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (20.97M versus 3.89M). Which is the better fit depends on your goals.
| DKHH | RGAS | |
|---|---|---|
Market Cap | 160.67B | 312.28B |
Volume | 20.97M | 3.89M |
Lot | 209.75K | 38.94K |
Turnover | 1.37B | 823.55M |
Average Price | 65.25 | 211.48 |
Value | 1.37B | 823.55M |
Indicative Equilibrium Price | 64 | 214 |
Indicative Equilibrium Volume | 1.35K | 179.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →